Key Takeaways
- The Department of Energy has granted approval for the Documented Safety Analysis (DSA) of Oklo’s Groves Isotope Test Reactor located in Lockhart, Texas, representing the final safety checkpoint before operations commence.
- With this approval secured, the reactor enters the DOE’s concluding pre-startup evaluation phase, aiming for first criticality by July 2026.
- This marks a historic achievement as Groves becomes the first advanced reactor situated on private property to obtain DSA clearance, utilizing entirely commercial fuel and equipment sources.
- Shares of OKLO experienced a 5% surge during premarket hours following the announcement; the company maintains a $9.1 billion valuation despite declining 27% in the last half-year.
- It’s important to note that Groves functions as an isotope production facility rather than an electricity generator — Oklo’s power generation plans depend on its Aurora powerhouse platform, currently under development.
A significant regulatory milestone has been achieved for Oklo’s Groves Isotope Test Reactor in Lockhart, Texas. On Wednesday, the U.S. Department of Energy granted approval for the facility’s Documented Safety Analysis, advancing Oklo closer to launching its inaugural reactor operation.
Shares of OKLO experienced a 5% uptick during premarket trading following the announcement. The company currently maintains a $9.1 billion market valuation, despite experiencing a 27% decline over the previous six-month period.
The approval of the DSA represents the completion of the facility’s ultimate safety documentation requirement. Having secured this clearance, Groves transitions into the DOE’s concluding pre-startup evaluation phase — encompassing a comprehensive readiness assessment and startup authorization before nuclear fuel loading and testing operations can commence.
The company has set July 2026 as its target date for achieving first criticality at Groves. This milestone marks the point when a reactor successfully establishes a controlled, self-sustaining nuclear chain reaction.
The timeline carries significance. Last year, Oklo received selection for a DOE program aimed at deploying a minimum of three test reactors at national laboratories by Independence Day 2026. The company has verified it remains on schedule to achieve this objective.
In a public statement, CEO Jacob DeWitte characterized it as a landmark achievement, emphasizing that Groves represents “the first advanced reactor project to receive approval of its Documented Safety Analysis that is on privately owned land, with wholly commercially sourced fuel, equipment, and systems delivered by the private sector.”
Construction on the Groves facility commenced less than twelve months ago. A private-sector team has overseen construction and operational preparations under DOE supervision.
Understanding Groves’ Function
Clarity regarding Groves’ actual purpose is essential. This reactor serves as an isotope production facility rather than an electricity-generating power plant.
Its primary function involves producing radioisotopes essential for cancer diagnostics and treatment, advanced manufacturing processes, scientific research initiatives, space exploration missions, and national security applications. The United States presently relies substantially on international suppliers and outdated domestic infrastructure for these critical materials.
Oklo’s electricity generation objectives are connected to its Aurora powerhouse concept, a fast fission reactor being developed at Idaho National Laboratory. A fuel fabrication plant is simultaneously under construction at that location. The DOE has previously granted approval for the Preliminary Documented Safety Analysis associated with the Aurora initiative.
Additional Developments
Beyond Groves, Oklo has maintained significant activity across multiple fronts. The company recently completed the acquisition of Creative Engineers, Inc., a specialized firm with deep knowledge in sodium and alkali-metal systems.
Additionally, the company executed a Letter of Intent with Centrus Energy Corp. for the procurement of high-assay low-enriched uranium (HALEU) designated for its Aurora powerhouse facility in Ohio, with delivery commencement anticipated in 2029.
Oklo and Standard Nuclear have established a memorandum of understanding to investigate nuclear fuel recycling possibilities and advanced fuel manufacturing techniques, concentrating on materials from a proposed facility in Oak Ridge, Tennessee.
Guggenheim recently launched coverage of Oklo with a neutral designation, forecasting EBITDA profitability by 2030.
According to InvestingPro analysis, Oklo maintains a stronger cash position than debt obligations on its balance sheet. The same evaluation suggests the stock trades at a slight premium relative to its Fair Value calculation.
The subsequent formal milestone for Groves involves the DOE’s readiness examination and startup authorization before fuel loading operations can advance.





